• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Change and Constancy: The 2025 CLFS Update

Change and Constancy: The 2025 CLFS Update

by Michael Schubert, PhD | Jan 21, 2025 | CMS-lca, Essential, Fee Schedules-lir, Funding-lir, Lab Industry Advisor, Reimbursement-lir

The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
2024 Laboratory Reimbursement Trends and What to Expect in 2025

2024 Laboratory Reimbursement Trends and What to Expect in 2025

by Tara Cepull, MA | Dec 18, 2024 | Essential, Lab Industry Advisor, Reimbursement-lca

Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Using AI to Improve Reimbursement and Decrease Claim Denials

Using AI to Improve Reimbursement and Decrease Claim Denials

by Tara Cepull, MA | Sep 26, 2024 | Essential, Lab Industry Advisor, Reimbursement-lca

Though payers’ adoption of AI has made reimbursement more challenging for labs, providers can also use AI to address these issues

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Private Payer Reimbursement for Genetic Testing Hinges on Clinical Utility

Private Payer Reimbursement for Genetic Testing Hinges on Clinical Utility

by Tara Cepull, MA | Sep 3, 2024 | Essential, Lab Industry Advisor, Reimbursement-lca

Two revenue cycle management experts offer tips for clinical labs to improve coverage decisions for genetic tests

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Electronic Prior Authorization Bill Reintroduced in Congress

Electronic Prior Authorization Bill Reintroduced in Congress

by Tara Cepull, MA | Sep 3, 2024 | Essential, Health care reform-nir, Lab Industry Advisor, Legislation-lca

For clinical labs, the proposed law could bring more consistency to test ordering

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com